Title: | Process of approving Ansaid as a drug |
Alternate title: | FDA premarket approval : process of approving Ansaid as a drug : GAO report to Congressional requesters |
Alternate title: | FDA premarket approval of Ansaid |
Author: | United States. General Accounting Office |
Note: | The Office, 1992 |
Link: | page images at HathiTrust |
No stable link: | This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links. |
Subject: | Anti-Inflammatory Agents, Non-Steroidal |
Subject: | Drugs -- Safety regulations -- United States -- Administration -- Evaluation |
Subject: | Fat substitutes -- Evaluation -- United States |
Subject: | Fat substitutes -- United States -- Patents |
Subject: | Nonsteroidal anti-inflammatory agents -- United States -- Patents |
Subject: | Patent |
Subject: | Patent extensions -- United States |
Subject: | United States. Food and Drug Administration -- Auditing |
Subject: | United States -- Food and Drug Administration |
Subject: | Upjohn Company -- Auditing |
Other copies: | Look for editions of this book at your library, or elsewhere. |
Help with reading books -- Report a bad link -- Suggest a new listing
Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials
Books -- News -- Features -- Archives -- The Inside Story
Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.